Neoadjuvant therapy reduces risk of secondary primary cancer in early-stage breast cancer

Neoadjuvant radiotherapy in patients with early-stage breast cancer significantly lowers the risk of developing secondary primary tumours at any site, new findings suggest.
Specialty Pharmacy Times